CLOCK is suggested to associate with comorbid alcohol use and depressive disorders by Sjöholm, Louise K et al.
RESEARCH Open Access
CLOCK is suggested to associate with comorbid
alcohol use and depressive disorders
Louise K Sjöholm
1*, Leena Kovanen
2,3, Sirkku T Saarikoski
3, Martin Schalling
1, Catharina Lavebratt
1, Timo Partonen
2
Abstract
Background: Depression and alcohol abuse or dependence (AUD) co-occur in the general population more
frequently than expected by chance. Alcohol use influences the circadian rhythms generated by the central
pacemaker in the suprachiasmatic nucleus, and circadian rhythm alterations in turn are common in depressive
disorders as well as among persons addicted to alcohol.
Methods: 32 SNPs in 19 circadian clockwork related genes were analyzed using DNA from 76 individuals with
comorbid depression and AUD, 446 individuals with AUD and 517 healthy controls with no psychiatric diagnosis.
The individuals participated in a nationwide health examination study, representative of the general population
aged 30 and over in Finland.
Results: The CLOCK haplotype TTGC formed by SNPs rs3805151, rs2412648, rs11240 and rs2412646, was associated
with increased risk for comorbidity (OR = 1.65, 95% CI = 1.14-2.28, P = 0.0077). The SNPs of importance for this
suggestive association were rs2412646 and rs11240 indicating location of the functional variation in the block
downstream rs2412648. There was no indication for association between CLOCK and AUD.
Conclusion: Our findings suggest an association between the CLOCK gene and the comorbid condition of alcohol
use and depressive disorders. Together with previous reports it indicates that the CLOCK variations we found here
may be a vulnerability factor to depression given the exposure to alcohol in individuals having AUD.
Background
Depression, alcohol abuse or dependence (AUD), as well
as other affective disorders and substance use disorders
(SUD), co-occur in the general population more fre-
q u e n t l yt h a ne x p e c t e db yc h a n c e[ 1 , 2 ] .A p p r o x i m a t e l y
80% of individuals with AUD report symptoms of
depression and 25-40% of the people suffering from
depression also report drinking problems [3]. The
comorbidity of depression and AUD complicates the
treatment and can alter the prognosis [3,4]. Further-
more, both depression and AUD increase the risk of sui-
cide. Hence, having both depression and AUD is more
severe than having just one of the disorders and it often
leads to greater impairment [5,6].
A number of hypotheses have been proposed to
explain the comorbidity between depression and AUD
and answer to whether we are dealing with one or two
independent and overlapping disorders. The comorbidity
could be due to shared risk factors or highly correlated
risk factors [1]. Also, some symptoms of AUD overlap
with some common symptoms in depression, such as
sadness and sleep disturbances [3]. It has also been dis-
cussed whether the co-occurrence could be the result of
one of the disorders increasing the risk for or even
aggravating the other disorder [1,3]. Alcohol dependent
individuals are possible at higher risk of developing
depression, as a consequence of the associated interper-
sonal and social problems often caused by alcohol
dependence [1]. On the contrary, the substance induced
mood disorder theory advocates that depressed persons
are more vulnerable to develop an addiction/abuse.
Related to this latter assumption is the self medication
theory, where the depressed individual tries to self-med-
icate with alcohol [1-3].
Depression and AUD are both complex disorders
meaning that both genetic and environmental risk fac-
tors have an influential role, with the interplay between
genes of modest effect with several environmental risk
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from several studies indicate that both environmental
and genetic risk factors partly overlap between depres-
sion and AUD suggesting a common etiology [7,8]. An
epidemiological study by Prescott and colleagues on
depression and alcoholism conclude that the causes
overlap between the disorders, though without having
the same origin and they estimated that the shared over-
lap of genetic and environmental factors influencing
depression and AUD was only 9-14% [4]. Nevertheless,
several genes have been proposed to be involved in the
etiology of both depression and AUD, exemplified by
brain-derived neurotrophic factor (BDNF), neuropeptide
Y( NPY), dopamine receptor D2 (DRD2), catechol-O-
methyltransferase (COMT), monoamine oxidase A
(MAOA), period homolog 2 (PER2) and several subtypes
of the serotonin receptor [8-12]. Only few studies have
investigated the genetic component of the co-occurrence
between depression and AUD. McEachin et al. investi-
gated the comorbidity between depression and AUD in
silico, by modeling gene-by-environment interactions
using bioinformatics and identified tumor necrosis fac-
tor (TNF) and methylenetetrahydrofolate reductase
(MTHFR) as candidate genes. TNF is involved in the
pathway activating MTHFR expression and excessive
alcohol intake leads to reduced TNF signaling. MTHFR
is a key component of the folate metabolism and pre-
viously folate levels have been associated to both depres-
sion and AUD [7]. In addition, linkage to chromosome
1p13-35 locus and alcoholism or depression has been
found, the region containing several genes includes two
genes coding for potassium channel-related proteins
[13].
Alcohol is known to influence and alter the circadian
rhythm and it may even act on the central pacemaker
located in the suprachiasmatic nucleus (SCN) [14]. Stu-
dies also show that alcohol preference and sensitivity
vary along with the circadian oscillation [15,16]. Studies
show that rats and other rodents have a preference for
alcohol during their active phase (dark-phase) [15].
Drug-induced changes of gene expression have been
reported for several clock genes and the CLOCK:
ARNTL transcription activity was increased in in vivo
experiments when stimulating the dopamine D2 recep-
tor [16]. The Period (Per) genes in rats have an
decreased circadian expression pattern in SCN and var-
ious other brain areas after alcohol intake [17]. Spanagel
and colleagues found that a haplotype in the PER2 gene
associated with high (>300 g/day) versus low (<300 g/
day) alcohol intake, though it was not associated with
alcohol dependence [18]. Also, both non-seasonal and
seasonal unipolar depressive and bipolar disorders and
certain sleep disorders are associated with an abnormal
circadian rhythm and display symptoms like disturbed
sleep-wake cycle and appetite, as well as abnormal phy-
sical functions including changes in temperature and
various hormonal levels [19-21].
Our aim here was to investigate whether certain
genetic variations in the circadian clock system are asso-
ciated with comorbidity between depression and AUD.
Methods
Material
The study groups were selected from the Health2000
study which is a population based Finnish nationwide
health interview and examination survey (for more
information, see http://www.terveys2000.fi/indexe.html
or http://www.kela.fi/in/internet/liite.nsf/%28WWWAll-
DocsById%29/947B8325F4EF9801C225744A0029D9BC/
$file/tutkimuksia86.pdf. The individuals with both a
depression diagnosis and an alcohol use diagnosis
(AUD), n = 76, were selected, as well as the 446 indivi-
duals with AUD only (without other mental disorder)
and 517 sex and age-matched healthy controls with no
psychiatric symptom (Table 1). The depression and
AUD diagnoses were based on the Composite Interna-
tional Diagnostic Interview (M-CIDI) and diagnoses
were set according to the DSM-IV criteria (codes:
296.2× or 296.3× major depressive disorder, 300.4 dys-
thymia, 305.00 alcohol abuse, 303.90 alcohol depen-
dence). The individuals with depression and AUD
comorbidity (cases) were compared to healthy indivi-
duals (controls) referred to as Sample set 1. Two addi-
tional sample sets were used to investigate possible
findings in Sample set 1. All the sample sets are dis-
played in Table 2.
Table 3 describes the comorbid cases and healthy con-
trols based on the modified 6-item Global Seasonality
Score (GSS) [22], the 21-item modified Beck Depression
Inventory (BDI) [22], the 12-item General Health Ques-
tionnaire (GHQ) [22], the 16-item Maslach Burn Out
Inventory - General Survey (MBI) [23] and the length of
sleep per day. The GSS assesses seasonal changes in mood
and behavior. In the modified GSS questionnaire each of
the six items was scored from 0 to 3 (none, slight, moder-
ate or marked change), with higher scores indicating
greater seasonal changes. The modified questionnaire was
good in representing the adult Finnish population, the
scores of 0 to 7 assigned as low and those of 8 to 18 as
high [24]. Modification was made to the 21-item BDI giv-
ing a sum score ranging from 0 to 55. The modified BDI
was validated in the Finnish population where the scores
of 0 to 9 assigned as low and 10 to 55 as high degree of
depressive symptoms. The GHQ scale evaluates whether
the individual complains about a recent symptom or beha-
vior. GHQ is a valid screening tool and a measure of psy-
chological distress at population level, especially
concerning anxiety and depression. According to the
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Examination Survey, the scores of 0 to 4 assigned as low
and those of 5 to 36 as high mental ill-being. The MBI
score for burnout was weight calculated as 0.4 × exhaus-
tion + 0.3 × cynicism + 0.3 × diminished professional effi-
cacy. A score of >1.49 indicates burnout and corresponds
to symptoms on a monthly basis or more frequently. In
this study, the GSS, BDI, GHQ and MBI scores were sig-
nificantly higher for cases than controls (Sample set 1) (P
< 0.0001).
Single-nucleotide polymorphism (SNP) selection and
genotyping
In total, 39 SNPs in 20 circadian clockwork related
genes were selected. Candidate SNPs, with a possible
functionality (e.g. amino acid changes or published data
on functional alterations) and/or prior published asso-
ciations to substance use or mental health disorders, in
circadian clock genes but also genes upstream or down-
stream in circadian pathways were selected. In addition,
tagSNPs from HapMap were selected, to increase the
variation coverage within core clock genes. Genomic
DNA was isolated from whole blood according to stan-
dard procedures. SNPs were genotyped with a fluoro-
genic 5’ nuclease assay method (TaqMan™) with both
pre-designed and custom made primer-probe kits (Taq-
Man® Pre-Designed SNP Genotyping Assays, Applied
Biosystems, Foster City, CA, USA) using Applied Biosys-
tems 7300 Real Time PCR System (Applied Biosystems)
according to manufacturers’ instructions. Custom made
assays were made for Adenosine deaminase (ADA)
22G>A (Asp8Asn), farnesyl-diphosphate farnesyltrans-
ferase 1 (FDFT1) rs11549147 and PER2 10870 (Addi-
tional file 1, Table S1). Of the 39 SNPs, rs35878285 in
ARNTL2, S662G in PER2 and rs2863712 in CRY2 and
rs2230783 in NCOA3 were non-polymorphic. The
rs934945 in PER2, and rs6486120 and rs1982350 in
ARNTL were also excluded as the controls were not (P
< 0.05) in Hardy-Weinberg equilibrium (HWE). Finally,
32 SNPs in 19 genes were further analyzed (Table 4).
All laboratory procedures were carried out blind to
case/control status. Five percent of the samples were
regenotyped and showed no error.
Statistical analyses
HWE for all SNPs were calculated for the control group.
Allele and genotype frequency differences between cases
a n dc o n t r o l s( S a m p l es e t1 )w ere tested using logistic
regression controlling for gender, due to over-represen-
tation of females in the case group (Table 1) applying
the PLINK program http://pngu.mgh.harvard.edu/pur-
cell/plink/, version 1.05 [25] and the R software http://
www.r-project.org/, version 2.10.0, package stats [26],
respectively. To obtain empirical significance, permuta-
tion tests with 10,000 permutations were calculated.
SNPs which showed nominal association (P < 0.05, alle-
lic or genotypic) were tested for association also in Sam-
ple sets 2 and 3 (Table 2).
The linkage disequilibrium (LD) measure D’ was cal-
culated among the controls and blocks were constructed
using the Haploview program, version 3.2 [27] using the
block parameters [28] and the D’ confidence interval
algorithm in the Haploview program. Test for haplotype
frequency difference between cases and controls in Sam-
ple set 1 was performed for the haplotype blocks har-
boring nominally associated SNPs (P < 0.05), being one
block in CLOCK. Nominal haplotype association in
Sample set 1 was then also analyzed in Sample sets 2
and 3. The PLINK program was used to perform the
calculations and gender was controlled for.
With the number of tests being performed in this
study an ordinary Bonferroni correction seemed
Table 1 Descriptive statistics of the study group.
Diagnosis Number
(n)
Mean age
± SEM
Females
%
Depression or Dysthymia + Alcohol dependence or abuse diagnosis (AUD) 76 46.6 ± 1.220 43.3
Individuals with an alcohol dependence or abuse diagnosis (AUD) 446 47.1 ± 0.550 15.1
Individuals without an alcohol or dependence diagnosis (AUD) 517 46.2 ± 0.494 19.5
Total 1039
Table 2 The Sample sets used.
Sample sets Cases
number n
Controls
number n
1. Depression or Dysthymia + AUD diagnosis vs individuals without psychiatric symptoms 76 517
2. Individuals with an AUD diagnosis vs individuals without psychiatric symptoms 446 517
3. Depression or Dysthymia + AUD diagnosis vs individuals with and without an AUD diagnosis 76 963
The SNPs found nominally associated (P < 0.05) in Sample set 1 were investigated in Sample sets 2 and 3.
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selection process being used in this study, i.e. choosing
genes and SNPs based on biological relevance. Nor does
the Bonferroni correction consider the LD between the
SNPs [29]. Therefore, threshold for significance was cal-
culated using a Bonferroni correction considering the
partial LD between SNPs. The nominal significance level
was divided by the number of SNP-groups (24) defined
by D’>0.80 among the controls [30,31]. The difference
in allele, genotype or haplotype frequency for the three
Sample sets was regarded significant if P < 0.0021 (0.05
divided by 24).
Power to detect allele frequency difference for Sample
set 1 was ≥ 0.8 for an OR ≥ 2.0 at allele frequency ≥ 0.3,
or for an OR ≥ 2.2 at allele frequency ≥ 0.2. For Sample
set 2, the power to detect allele frequency difference
was ≥ 0.8 for an OR of ≥ 1.5 at allele frequency ≥ 0.3,
or for an OR of ≥ 1.6 at allele frequency ≥ 0.2.
Table 3 Descriptive statistics of the continuous variables for Sample set 1.
Variable name Score range Group Total n Min-Max Median
6-item Global Seasonality Score* (GSS) 0-18 Cases 76 0-13 6.00
Controls 517 0-18 4.00
21-item Beck Depression Inventory* (BDI) 0-55 Cases 76 0-44 18.50
Controls 517 0-24 3.00
12-item General Health Questionnaire* (GHQ) 0-36 Cases 76 0-12 7.00
Controls 517 0-12 0.00
Maslach Burnout Inventory-General* (MBI) 0-16 Cases 76 0.26-4.73 2.18
Controls 517 0.00-3.88 0.79
Length of night sleep (h) 4-12 Cases 76 4-12 6.00
Controls 517 4-11 7.00
* GSS, BDI, GHQ and MBI scores were higher for cases than controls in Sample set 1 (P < 0.0001).
Table 4 The 19 circadian clockwork related genes and the 32 SNPs analyzed.
Gene Gene name Location ID (rs#) of SNPs genotyped
ARNTL Aryl hydrocarbon receptor nuclear translocator-like 11p15.2 (rs2290035, rs3816360, rs2278749)
ARNTL2 Aryl hydrocarbon receptor nuclear translocator-like 2 12p12.2-p11.2 (rs4964057, rs2306074, rs7958822, rs1037921)
CLOCK Clock homolog (mouse) 4q12 (rs3805151, rs2412648, rs11240, rs2412646)
NPAS2 Neuronal PAS domain protein 2 2q11.2 (rs11541353, rs2305160)
PER2 Period homolog 2 (Drosophila) 2q37.3 (Spanagel/10870, rs2304672)
TIMELESS Timeless homolog (Drosophila) 12q13.2 (rs2291739, rs2291738)
ACADS Acyl-Coenzyme Adehydrogenase,
C-2 to C-3 short chain
12q22-qter (rs1799958/rs17848088)
ADA Adenosine deaminase 20q12-q13.11 (Asp8Asn)
ADCYAP1 Adenylate cyclase activating polypeptide 1 (pituitary) 18p11.32 (rs2856966)
DRD2 Dopamine receptor D2 11q23.1 (rs6277)
ANKK1 Ankyrin repeat and kinase domain containing 1 11q23.1 (rs1800497)
FDFT1 Farnesyl-diphosphate farnesyltransferase 1 8p23.1-p22 (rs11549147)
GLO1 Glyoxalase I 6p21.3-p21.1 (rs2736654)
OPN4 LIM domain binding 3;opsin 4 (melanopsin) 10q23.2 (rs1079610)
NCOA3 Nuclear receptor coactivator 3 20q13.12 (rs6094752, rs2230782)
NPY Neuropeptide Y 7p15.1 (rs16139)
PLCB4 Phospholipase C, beta 4 20p12 (rs6077510)
VIP vasoactive intestinal peptide 6q25.2 (rs3823082, rs688136)
VIPR2 Vasoactive intestinal peptide receptor 2 7q36.3 (rsS885863)
Symbol approved by the HUGO Gene Nomenclature Committee (HGNC) database http://www.genenames.org/, the location and rs# were taken from the NCBI
Entrez Gene and dbSNP BUILD 129 database respectively http://www.ncbi.nlm.nih.gov/. TagSNPs were selected using HapMap (The International HapMap
Consortium, 2005). Note: Historically DRD2 Taq1A (rs1800497) has been assigned to DRD2 whereas more recent data have indicated that the SNP is actually
located within the coding region of ANKK1.
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compared between cases and controls (Sample set 1)
using the Mann-Whitney U test, since the variables were
not normally distributed in the control group, in PASW
version 18.0.0 [32]. Significant difference was set to P <
0.05/4 (four variable groups with r < 0.6). Where differ-
ence between cases and controls were found, association
between the variable and the nominally associated SNPs
were investigated with univariate linear regression with
SNP as predictor using PLINK. Gender was not included
since it did not contribute to the genetic additive model.
Results
Allele and genotype frequencies of SNPs in circadian
genes (Table 4) were tested for association with depres-
sion and AUD comorbidity as compared to healthy con-
trols (Sample set 1, Table 2). For SNPs with nominal
allele or genotype association (P < 0.05), genetic associa-
tion analyses with AUD versus healthy controls (Sample
set 2) and comorbidity versus AUD and controls (Sam-
p l es e t3 )w e r ep e r f o r m e dt od e t e r m i n et h en a t u r eo f
the association to the comorbidity. The results are pre-
sented in Table 5.
In the CLOCK gene the minor allele G of rs11240 was
suggestively associated with depression and AUD
comorbidity and showed an OR of 1.65 (P = 0.0077).
This was further strengthened by the results from the
recessive model (GG vs GC and CC, P = 0.013) and
trend test (P = 0.0077). Rs11240 showed no associations
to AUD in Sample set 2. Accordingly, in Sample set 3
the allele G was suggestively associated with risk for
depression (OR = 1.59, P = 0.0084) and the Cochran-
Armitage test suggested a trend (P = 0.0082).
One LD block was formed in CLOCK (rs3805151,
rs2412648, rs11240, rs2412646), spanning a 18-kb
region, using Sample set 1 data. The haplotype TTGC,
including the rs11240 risk allele G, suggestively con-
ferred a risk for comorbidity (OR = 1.65, P = 0.0077)
(Table 6). This TTGC haplotype was suggestively asso-
ciated also with an increased risk for depression in Sam-
ple set 3 (OR = 1.50, P = 0.0084). Three additional
haplotypes were formed, however none of then nomin-
ally associated, TTCT, CGCC and CTCC with overall
frequencies of 26%, 36% and 3.8% respectively. To eluci-
date TT alleles role in the two haplotypes, analysis was
performed with only the last two SNPs in the haplotype
(rs11240 and rs2412646). The p-values for the risk hap-
lotypes did not change between the TTGC and the GC
haplotypes in Sample set 1 (Table 6) indicating location
of the functional variation downstream of rs2412648.
The rs2306074 in ARNTL2 showed a border-line
nominal Cochran-Armitage trend in Sample set 1 (P =
0.043), and no indication for association in Sample sets
2a n d3 .I nACADS, the A allele of rs1799958 showed a
border-line nominal allelic association of increased risk
for comorbidity (OR = 1.47, P = 0.045) and a trend test
supported the finding (P = 0.045). Likewise, in Sample
set 3 a very modest nominal allelic association was
found for rs1799958 (P = 0.046). No haplotype could be
constructed for ARNTL2 or ACADS that included the
SNPs nominally associated with comorbidity.
To test for a quantitative effect of the CLOCK
rs11240, ACADS rs1799958 and ARNTL2 rs2306074 on
AUD depression comorbidity, these variations were
tested for association to GSS, BDI, GHQ and MBI
among the comorbid cases only. The A allele of
Table 5 SNP allele and genotype frequency association analysis for the three Sample sets.
Gene Function SNP Alleles Sample
set
MAF A/U OR
(95% CI)*
P-values allele P-values genotype
* Empirical Cochran-
Armitage
trend*
Dominant
model*
Recessive
model*
CLOCK Intron rs11240 G/C 1. 0.44/0.33 1.65 (1.14-2.38) 0.0077 0.0072 0.0077 0.055 0.013
2. 0.33/0.33 1.02 (0.85-1.24) Ns Ns Ns Ns Ns
3. 0.44/0.33 1.59 (1.13-2.26) 0.0084 0.0068 0.0082 0.048 0.016
ARNTL2 Intron rs2306074 C/T 1. 0.30/0.35 0.77 (0.53-1.12) Ns Ns Ns 0.043 Ns
2. 0.33/0.35 0.90 (0.74-1.09) Ns Ns Ns Ns Ns
3. 0.30/0.34 0.80 (0.55-1.15) Ns Ns Ns 0.056 Ns
ACADS Mis-sense
mutation
rs1799958 A/G 1. 0.34/0.26 1.47(1.01-2.15) 0.045 0.044 0.045 0.097 Ns
2. 0.28/0.26 1.11(0.91-1.37) Ns Ns Ns Ns Ns
3. 0.34/0.27 1.44(1.01-2.07) 0.046 0.040 0.046 0.097 Ns
SNPs which showed nominal association (allelic or genotypic) P < 0.05 for Sample set 1 are displayed as are the p-values P < 0.1. Ns = non significant. Analysis in
Sample set 2 and 3 were then performed for these SNPs. Alleles: the minor allele first. Odds ratio (OR): the proportion of minor versus major allele in the affected
(A) divided by the proportion of minor versus major allele in the non-affected (U) individuals. Empirical P is the point-wise P-value after 10,000 permutations.*
gender was used as covariate.
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higher GHQ score among cases (P = 0.031).
Discussion
Our results herein suggest that the circadian gene
CLOCK is associated with comorbid depression and
AUD, but not with AUD only. The haplotype TTGC
formed by SNPs rs3805151, rs2412648, rs11240,
rs2412646 was suggestively associated with increased
risk for the comorbidity, with the odds ratio of 1.65.
The SNPs of importance for this suggestive associa-
tion were rs11240 and rs2412646, indicating location
of the functional variation downstream of rs2412648.
No indication of association with CLOCK was found
when comparing AUD with healthy controls. Accord-
ingly, the suggestive association to CLOCK was seen
when comparing comorbid cases with combined
group of healthy controls and persons diagnosed with
AUD. This CLOCK variation may be a vulnerability
factor for depression given the alcohol exposure in
AUD but not considerably increasing the risk for
depression without AUD. This view is supported by
the findings from other studies of the Finnish general
population through the Health 2000 Study. They
could not detect any CLOCK association with major
depressive disorder or dysthymia [33] or anxiety dis-
orders (Sipilä et al., submitted 2009), each using a
disorder focused set of samples inclusive of all the
cases. These studies analyzed rs10462028 and
rs1801260 [33], and rs3749474 and rs1801260 (Sipilä
et al., submitted 2009) that are in high LD with
rs11240 analyzed in the current study (according to
HapMap public release) [34]. Neither could we detect
any indication that CLOCK variation was associated
with AUD only. In agreement, the shared overlap of
genetic and environmental factors influencing depres-
sion and AUD was estimated to only 9-14% out of
which 50-60% was attributed to shared genetic fac-
tors. Also, Prescott and colleagues found no support
that comorbidity arises from depression causing alco-
holism or alcoholism causing depression using struc-
tural modeling in twins [4].
The CLOCK gene is one of the most central genes in
the circadian system and has been studied in a wide
r a n g eo fa r e a sd u et oi t sc r u c i a lr o l ei nc r e a t i n ga n d
maintaining the body’s internal rhythm. CLOCK protein
exhibits a regulatory role as transcription factor over
other circadian genes, like the CRYsa n dPERs, together
with ARNTL or ARNTL2 protein. The CRY and PER
c o m p l e x e se x h i b i tar e g u l a t o r yr o l ea sr e p r e s s o r sa n d
inhibit the transcription of CLOCK and ARNTL and
thereby themselves, when reaching a critical concentra-
tion. This transcription-translation feedback loop takes
approximately 24 hours [21,35].
Individuals with depression or AUD often have circa-
dian misalignment and many physiological phenomena
such as the sleep-wake cycle and hormonal profiles are
disrupted [36]. Sleep disturbances are also pronounced
symptoms of a wide range of circadian rhythm disor-
ders such as familial advanced sleep-phase syndrome
(FASPS), delayed sleep phase syndrome (DSPS), as well
as other psychiatric disorders like seasonal and non-
seasonal mood disorders like, bipolar, schizophrenia as
well as in drug addictions [37,38]. Furthermore, sleep
deprivation and light therapy have an antidepressant
effect synchronizing the sleep-wake cycle with the cir-
cadian rhythms, indicating the important role that the
circadian system plays in many psychiatric disorders
[19,39].
Individuals addicted to alcohol show circadian altera-
tions, for example sleep disturbances [36]. As previously
mentioned, alcohol has the ability to induce clock gene
expression in different brain areas [18]. Ruby et al.
showed evidence that ethanol significantly affects photic
and non-photic phase-resetting responses in hamsters,
critical for circadian regulation, by blocking the phase-
resetting action of glutamate and increase the non-pho-
tic phase-resetting action of serotonin. This signal inhi-
bition from ethanol was manifested through direct
action in the core clock in SCN [40]. The preference
and sensitivity to alcohol also seems to vary with the
time of day [15].
Clinical effect of variations in CLOCK has been quite
extensively studied. The SNP rs1801260 in CLOCK
Table 6 Haplotype association analysis of CLOCK.
SNP block Haplotype Sample set Overall frequency OR (95% CI) P-value
rs3805151-rs2412648-rs11240-rs2412646 TTGC 1. 0.34 1.65 (1.14-2.28) 0.0077
2. 0.33 Ns Ns
3. 0.34 1.50 (1.14-2.27) 0.0084
rs11240-rs2412646 GC 1. 0.34 1.65 (1.15-2.29) 0.0077
2. 0.28 Ns Ns
3. 0.34 1.50 (1.14-2.27) 0.0084
Ns = non significant (P > 0.1). Odds ratio (OR): the ratio specific haplotype versus all other haplotypes among the cases, relative to the ratio specific haplotype
versus all other haplotypes among the controls. Gender was used as covariate.
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individuals, where C allele carriers had a higher eve-
ning preference. The same allele was also associated
with the delay in sleep phase and insomnia in major
depression and bipolar affective disorder patients
[41,42]. Later, Serretti and colleagues also showed that
the C/C genotype of rs1801260 was associate with the
severity of insomnia in depressed and bipolar patients
during SSRIs treatment [43]. SSRIs have earlier been
reported to have circadian properties, inducing phase
shift in neuronal firing in the SCN in rats [44]. The
SNPs rs1801260 and rs11240 analyzed in the current
study are probably reflecting association to the same
functional polymorphism, as they are in LD with each
other and display the same minor allele frequency
(according to HapMap public release and NCBI Entrez
dbSNP) [34,45]. Alcohol and other drugs of abuse
modulate the dopamine neurotransmission, and
McClung and colleagues showed that the Clock gene
seems to increase the excitability of dopamine neurons
and also the cocaine reward in mice with a dominant
negative CLOCK protein that cannot activate tran-
scription [46]. These Clock-mutant mice also display
alcohol preference [47]. The CLOCK gene has also
been proposed to be involved in the metabolic syn-
drome, which involves obesity and increased the risk
for diabetes and heart disease [48].
Weak suggestive association to comorbidity was found
for rs2306074 in ARNTL2 and rs1799958 in ACADS.A
family study by Shi et al. found weak association between
rapid cycling and a diurnal mood, with worse symptoms
in the afternoon or evening, in bipolar subjects and SNPs
in ARNTL2 [49]. There is also some association of
ARNTL2 with social phobia (Sipilä et al., submitted
2009). Interestingly, there is a functional partnership
between ARNTL2 and PER2 [50] that might bridge social
phobia and alcohol use [51] to end in high alcohol intake.
Support for involvement of ARNTL2 in seasonal affective
disorder (SAD), a subtype of mood disorder that is clo-
sely related to AUD [52], has been reported by our
group, where a SNP association was seen in both Swedish
and Finnish materials (Sjöholm et al., submitted 2009). In
addition, ARNTL has been reported by our group to
show associations with depression in a Swedish popula-
tion-based and case-control material [11,53]. Moreover,
NPAS2 is indicated to associate with SAD [54,55] and
NPAS2 and ARNTL or ARNTL2 heterodimerize and pos-
sess a transcriptional modulation function as the
CLOCK/ARNTL complex [35].
ACADS, acyl-Coenzyme A dehydrogenase, C-2 to C-3
short chain, is an enzyme participating in the fatty acid
b-oxidation and has not previously been reported to
associate with mood disorder or AUD. Deficiency in
ACADS leads to changes in theta oscillations during
rapid eye movement (REM) sleep in mice [56], and in
the majority of depressed patients disturbed sleep archi-
tecture is characterized by abnormal timing and distri-
bution of REM and non-REM sleep stages give feedback
to the SCN [57]. Furthermore, there are abnormal long-
range temporal correlations in theta oscillations during
wakefulness [58] and profound REM sleep abnormalities
in patients with non-seasonal depressive disorder that
have melancholic depressive symptoms [14,39]. On the
other hand, non-REM sleep abnormalities, such as
abnormal cross-correlations between facial temperatures
and delta and theta frequencies, are found in patients
with SAD that have atypical depressive symptoms [59].
The rs1799958 SNP (G>A) in ACADS results in the
conversion of glycine to serine and associates with the
short chain acyl-CoA dehydrogenase deficiency [60] that
is characterized by lipid storage myopathy and muscle
weakness.
An advantage of this study is that the individuals are
derived from a big Finnish population based study of an
ethnically homogenous population that is nationwide
and representative of the general population aged 30 or
over. We were able to investigate whether our results
found with the comorbid versus control (without psy-
chiatric symptoms), Sample set 1, reflected genetic vul-
nerability to AUD. A limitation in our study is the small
size of the comorbid sample and the lack of a group of
patients having depressive disorder only. For now, repli-
cation of the findings in independent study samples is
needed as the most practical way to increase the prob-
ability of a true association.
Conclusion
The comorbid condition of alcohol use and depressive
disorders in the Finnish population was associated with
CLOCK genetic variations and there was no indication
for CLOCK gene association with AUD only. This find-
ing together with previous reports indicates that the
CLOCK variations we found here may be a vulnerability
factor for depression given the exposure to alcohol in
individuals having AUD.
Additional file 1: Table S1, list of primer sequences. The primer and
reporter sequences for the Custom TaqMan® SNP Genotyping Assay.
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